Swedish Orphan Biovitrum AB
12 products tracked · names used in filings: Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB (publ), Swedish Orphan Biovitrum International AB
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Gamifant emapalumab | Refused | |
| 🇪🇺 | Tryngolza olezarsen | Authorised | 2025-09-17 |
| 🇪🇺 | Altuvoct efanesoctocog alfa | Authorised | 2024-06-17 |
| 🇪🇺 | Zynlonta loncastuximab tesirine | Authorised | 2022-12-20 |
| 🇪🇺 | Aspaveli pegcetacoplan | Authorised | 2021-12-13 |
| 🇪🇺 | Doptelet avatrombopag | Authorised | 2019-06-20 |
| 🇪🇺 | Alprolix eftrenonacog alfa | Authorised | 2016-05-12 |
| 🇪🇺 | Elocta efmoroctocog alfa | Authorised | 2015-11-18 |
| 🇪🇺 | Xiapex collagenase Clostridium histolyticum | Withdrawn | 2011-02-28 |
| 🇪🇺 | Kepivance palifermin | Withdrawn | 2005-10-25 |
| 🇪🇺 | Orfadin nitisinone | Authorised | 2005-02-21 |
| 🇪🇺 | Kineret anakinra | Authorised | 2002-03-08 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.